CD40/CD154 interactions at the interface of tolerance and immunity.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Annual Review of Immunology

• Publication date

  2004-03-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.IMMUNOL.22.012703.104533PMID 15032580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulatory T cells

  2006cited by this paper
• T regulatory cells.

  2005cited by this paper
• [Regulatory T cells].

  2005cited by this paper
• Distinctive Maturation of In Vitro Versus In Vivo Anti-CD40 mAb-Matured Dendritic Cells in Mice

  2003cited by this paper
• Tolerogenic dendritic cells.

  2003cited by this paper
• Modulation of NF-κB Activity by Exchange of Dimers

  2003cited by this paper
• Co‐Stimulatory Blockade in the Treatment of Murine Systemic Lupus Erythematosus (SLE)

  2003cited by this paper
• Modulation of NF-kappaB activity by exchange of dimers.

  2003cited by this paper
• Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.

  2003cited by this paper
• Feedback regulation of pathogen-specific T cell priming.

  2003cited by this paper
• Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells.

  2003cited by this paper
• Regulatory lymphocytes: Regulatory T cells in transplantation tolerance

  2003cited by this paper
• Distinct contributions of different CD40 TRAF binding sites to CD154‐induced dendritic cell maturation and IL‐12 secretion

  2003cited by this paper
• Toll-Like Receptor Signaling Pathways

  2003cited by this paper
• Opinion-regulatory lymphocytes: Natural versus adaptive regulatory T cells

  2003cited by this paper
• Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10.

  2003cited by this paper
• Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• CD154 on the surface of CD4+CD25+ regulatory t cells contributes to skin transplant tolerance

  2003cited by this paper
• Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

  2003cited by this paper
• Studies Investigating Pretransplant Donor-Specific Blood Transfusion, Rapamycin, and the CD154-Specific Antibody IDEC-131 in a Nonhuman Primate Model of Skin Allotransplantation1

  2003cited by this paper
• Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity.

  2003cited by this paper
• Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation.

  2003cited by this paper
• Long-term limb allograft survival using anti-CD40L antibody in a murine model

  2003cited by this paper
• A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

  2003cited by this paper
• Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors1

  2002cited by this paper
• Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent

  2002cited by this paper
• BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

  2002cited by this paper
• Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses.

  2002cited by this paper
• Heat shock proteins as ligands of toll-like receptors.

  2002cited by this paper
• Dendritic cell development and survival require distinct NF-kappaB subunits.

  2002cited by this paper
• BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells.

  2002cited by this paper
• Treatment with anti-CD154 antibody and donor-specific transfusion prevents acute rejection of myoblast transplantation.

  2002cited by this paper
• Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity

  2002cited by this paper
• IFN-αβ Promote Priming of Antigen-Specific CD8+ and CD4+ T Lymphocytes by Immunostimulatory DNA-Based Vaccines1

  2002cited by this paper
• A Role for CD40 Expression on CD8+ T Cells in the Generation of CD8+ T Cell Memory

  2002cited by this paper
• Constitutive Presentation of a Natural Tissue Autoantigen Exclusively by Dendritic Cells in the Draining Lymph Node

  2002cited by this paper
• Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo

  2002cited by this paper
• Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ

  2002cited by this paper
• IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.

  2002cited by this paper
• HSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway*

  2002cited by this paper
• Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells

  2002cited by this paper
• Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance

  2002cited by this paper
• Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase

  2002cited by this paper
• Novel Signal Transduction Pathway Utilized by Extracellular HSP70

  2002cited by this paper
• Long-lived immature dendritic cells mediated by TRANCE-RANK interaction.

  2002cited by this paper
• Missing pieces in the NF-kappaB puzzle.

  2002cited by this paper
• CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and Responsiveness

  2002cited by this paper
• BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells

  2002cited by this paper
• The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells

  2002cited by this paper
• Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance

  2002cited by this paper
• Two Pathways to NF-κB

  2002cited by this paper
• Dendritic Cell Development and Survival Require Distinct NF-κB Subunits

  2002cited by this paper
• Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size1

  2002cited by this paper
• Toll-like receptors and their ligands.

  2002cited by this paper
• Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation.

  2002cited by this paper
• Two pathways to NF-kappaB.

  2002cited by this paper
• CD40 Ligation in the Presence of Self-Reactive CD8 T Cells Leads to Severe Immunopathology1

  2002cited by this paper
• Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease1

  2002cited by this paper
• Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes

  2002cited by this paper
• Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease1

  2002cited by this paper
• CD40L overexpression on T cells and monocytes from patients with systemic lupus erythematosus is resistant to calcineurin inhibition

  2002cited by this paper
• Co-Stimulatory Molecules in Islet Xenotransplantation: CTLA4Ig Treatment in CD40 Ligand-Deficient Mice

  2002cited by this paper
• The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

  2002cited by this paper
• The role of heat shock protein (hsp70) in dendritic cell maturation: Hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors

  2001cited by this paper
• IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

  2001cited by this paper
• Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.

  2001cited by this paper
• Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice

  2001cited by this paper
• IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo1

  2001cited by this paper
• The Clinical Course of Experimental Autoimmune Encephalomyelitis and Inflammation Is Controlled by the Expression of Cd40 within the Central Nervous System

  2001cited by this paper
• The role of CD154 in organ transplant rejection and acceptance.

  2001cited by this paper
• Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.

  2001cited by this paper
• Dendritic cell longevity and T cell persistence is controlled by CD154‐CD40 interactions

  2001cited by this paper
• CD40 pathway blockade as an approach to immunotherapy.

  2001cited by this paper
• Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.

  2001cited by this paper
• Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells

  2001cited by this paper
• The TNF Superfamily Members LIGHT and CD154 (CD40 Ligand) Costimulate Induction of Dendritic Cell Maturation and Elicit Specific CTL Activity1

  2001cited by this paper
• Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo

  2001cited by this paper
• Type 1 T regulatory cells

  2001cited by this paper
• CD40 stimulation accelerates deletion of tumor-specific CD8+ T cells in the absence of tumor-antigen vaccination

  2001cited by this paper
• Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice.

  2001cited by this paper
• IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1

  2001cited by this paper
• Cd4+Cd25+ Immune Regulatory Cells Are Required for Induction of Tolerance to Alloantigen via Costimulatory Blockade

  2001cited by this paper
• Blockade of the CD28 and CD40 pathways result in the acceptance of pig and rat islet xenografts but not rat cardiac grafts in mice.

  2001cited by this paper
• Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

  2001cited by this paper
• Mechanisms Involved in the Establishment of Tolerance Through Costimulatory Blockade and BMT: Lack of Requirement for CD40L‐Mediated Signaling for Tolerance or Deletion of Donor‐reactive CD4+ Cells

  2001cited by this paper
• Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12

  2001cited by this paper
• C-Rel Regulates Interleukin 12 P70 Expression in Cd8+ Dendritic Cells by Specifically Inducing p35 Gene Transcription

  2001cited by this paper
• Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo

  2000cited by this paper
• Role of Antigen-Presenting Cells in Mediating Tolerance and Autoimmunity

  2000cited by this paper
• Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion.

  2000cited by this paper
• CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.

  2000cited by this paper
• Regulatory T cells: key controllers of immunologic self-tolerance.

  2000cited by this paper
• Consequences of Cell Death

  2000cited by this paper
• Consequences of cell death: exposure to necrotic tumor cells

  2000cited by this paper
• CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection1

  2000cited by this paper
• The Toll receptor family and microbial recognition.

  2000cited by this paper
• Cutting Edge: Anti-CD154 Therapeutic Antibodies Induce Infectious Transplantation Tolerance1

  2000cited by this paper
• The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli

  2000cited by this paper

• Curbing Autoimmunity: A New Fab Fragment Targeting CD40‐CD40L Halts B‐Cell Activation and Differentiation

  2026cites this paper
• The X Factor in Immunity: Sex Differences Shaped by the X Chromosome

  2026cites this paper
• Red Blood Cell Transfusion is a Non-Canonical Immune Stimulus Characterized by the Suboptimal Induction of CD4+ T Cell Help

  2026influential citation
• Cross‐Cancer Perspectives on CD40 Agonist Therapy: Modulating the Tumor Immune Microenvironment

  2026cites this paper
• CD40 induces PIR-A+ macrophages to promote chronic allograft rejection.

  2025cites this paper
• CD40 Ligand and CD40: Expression, Regulation, and Function at the Maternal-Conceptus Interface in Pigs.

  2025cites this paper
• Efficacy of Using Dendritic Cells in the Treatment of Prostate Cancer: A Systematic Review

  2025cites this paper
• The role of CD40L-expressing CXCR5+CD8+ follicular cytotoxic T cells in chronic lymphocytic leukemia

  2025cites this paper
• Tissue resident memory B cells mediate protective immunity to respiratory pathogens in the airways.

  2025cites this paper
• In situ genetically engineering nanosystem for reversing immunosuppression of cancer-associated fibroblasts in breast cancer radiotherapy.

  2025cites this paper
• Lowering CD40L expression in Murine Lupus Results in an Increase in Disease Indicators in Female but not Male B6 mice

  2025cites this paper
• Regulatory effect of curcumin on CD40:CD40L interaction and therapeutic implications.

  2025cites this paper
• Differential lipids in euthyroid pregnant women with positive TPOAb and its correlation with clinical parameters

  2025cites this paper
• Immunogenicity Risk Assessment of Biotherapeutics Using an Ex Vivo B Cell Assay

  2025cites this paper
• Regulatory T cell and endothelial cell crosstalk

  2025cites this paper
• LGR4 (GPR48): The Emerging Inter-Bridge in Osteoimmunology

  2025cites this paper
• Insights into Immune Exhaustion in Chronic Hepatitis B: A Review of Checkpoint Receptor Expression

  2024influential citation
• Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity

  2024cites this paper
• Dysfunction of dendritic cells in tumor microenvironment and immunotherapy

  2024cites this paper
• Dendritic cell and co-stimulatory molecule targeted therapy for autoimmune diseases: a review of the newly implemented strategies

  2024cites this paper
• An overview of early genetic predictors of IgA deficiency

  2024cites this paper
• Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).

  2024cites this paper
• Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model

  2024cites this paper
• Small-molecule inhibitors of the CD40–CD40L costimulatory interaction are effective in pancreatic islet transplantation and prevention of type 1 diabetes models

  2024cites this paper
• Quantifying biomolecular organisation in membranes with brightness-transit statistics

  2024cites this paper
• Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment.

  2024cites this paper
• A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer

  2024cites this paper
• T cell responsiveness to IL-10 defines the immunomodulatory effect of costimulation blockade via anti-CD154 and impacts transplant survival

  2024cites this paper
• Co-stimulators CD40-CD40L, a potential immune-therapy target for atherosclerosis: A review

  2024cites this paper
• Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer

  2023cites this paper
• Tumor Cell Nanovaccines Based on Genetically Engineered Antibody‐Anchored Membrane

  2023cites this paper
• Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

  2023cites this paper
• Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies

  2023cites this paper
• Sex differences in susceptibility to substance use disorder: Role for X chromosome inactivation and escape?

  2023cites this paper
• Plasmacytoid dendritic cells: A dendritic cell in disguise.

  2023cites this paper
• Dual CSF1R inhibition and CD40 activation demonstrates anti-tumor activity in a 3D macrophage- HER2+ breast cancer spheroid model

  2023cites this paper
• A role for platelets in metabolic reprogramming of tumor-associated macrophages

  2023cites this paper
• Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine

  2023cites this paper
• The anti-CD40L monoclonal antibody AT-1501 promotes islet and kidney allograft survival and function in nonhuman primates

  2023cites this paper
• Impact of CD40 gene polymorphisms on the risk of cervical squamous cell carcinoma: a case-control study

  2023cites this paper
• Basic Understanding of Liver Transplant Immunology.

  2023cites this paper
• State of the art in childhood nephrotic syndrome: concrete discoveries and unmet needs

  2023cites this paper
• Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy

  2023cites this paper
• Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages

  2022cites this paper
• Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies.

  2022cites this paper
• Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment

  2022cites this paper
• Cytokines and Production of Aberrantly O-Glycosylated IgA1, the Main Autoantigen in IgA Nephropathy

  2022cites this paper
• Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy

  2022cites this paper
• siRNA against CD40 delivered via a fungal recognition receptor ameliorates murine acute graft‐versus‐host disease

  2022cites this paper
• Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis

  2022cites this paper
• Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity

  2022cites this paper
• Extensive involvement of CD40 and CD154 costimulators in multiple T cell-mediated responses in a perciform fish Larimichthys crocea.

  2022cites this paper
• Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems

  2022cites this paper
• Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study

  2022cites this paper
• The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis

  2022cites this paper
• Immunity to Cryptosporidium: Lessons from Acquired and Primary Immunodeficiencies.

  2022cites this paper
• CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model

  2022cites this paper
• Investigational drugs for the treatment of kidney transplant rejection

  2022cites this paper
• Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP).

  2022cites this paper
• A novel platform for the production of autologous human antibodies

  2022cites this paper
• IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms

  2022cites this paper
• sCD40L Is Increased and Associated with the Risk of Gestational Diabetes Mellitus in Pregnant Women with Isolated TPOAb Positivity

  2022cites this paper
• Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention

  2021cites this paper
• Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease

  2021cites this paper
• Systems pharmacology dissection of action mechanisms for herbs in osteoporosis treatment

  2021cites this paper
• Molecular cloning of duck CD40 and its immune function research

  2021cites this paper
• CD40 plays roles in T cell-dependent response and B cell activation and differentiation in Nile tilapia (Oreochromis niloticus)

  2021cites this paper
• Immune Response to SARS-CoV-2 Infection in Obesity and T2D: Literature Review

  2021cites this paper
• The role of the immune system in idiopathic nephrotic syndrome

  2021influential citation
• The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune Cells

  2021cites this paper
• Fibroblast Activation Protein α-Targeted CD40 Agonism Abrogates Systemic Toxicity and Enables Administration of High Doses to Induce Effective Antitumor Immunity

  2021cites this paper
• Identification and functional characterization of CD154 in T cell-dependent immune response in Nile tilapia (Oreochromis niloticus).

  2021cites this paper
• Distinct cDC subsets co-operate in CD40 agonist response while suppressive microenvironments and lack of antigens subvert efficacy

  2021cites this paper
• Therapeutic Approaches to Employ Monoclonal Antibody for Cancer Treatment

  2021cites this paper
• microRNA Fine-Tuning of the Germinal Center Response

  2021cites this paper
• The Concept of Co-Stimulatory Blockade in SLEplease remove Aff4

  2021cites this paper
• Simultaneous Inhibition of PD-1 and Stimulation of CD40 Signaling Pathways by Anti-PD-L1/CD40L Bispecific Fusion Protein Synergistically Activate Target and Effector Cells

  2021cites this paper
• Transcriptome analysis revealed that delaying first colostrum feeding postponed ileum immune system development of neonatal calves.

  2021cites this paper
• PD‐1/PD‐L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity

  2021cites this paper
• Estrogen receptor alpha, but not beta, is required for optimal dendritic cell differentiation and [corrected] CD40-induced cytokine production

  2021influential citation
• An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases.

  2021cites this paper
• Role of Immune Cell Diversity and Heterogeneity in Corneal Graft Survival: A Systematic Review and Meta-Analysis

  2021cites this paper
• Estrogen deficiency and the pathogenesis of osteoporosis

  2021cites this paper
• Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.

  2020cites this paper
• CMTM7 plays key roles in TLR‐induced plasma cell differentiation and p38 activation in murine B‐1 B cells

  2020cites this paper
• CD11b is a novel alternate receptor for CD154 during alloimmunity

  2020cites this paper
• Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy

  2020cites this paper
• Saccharomyces boulardii attenuates inflammatory response induced by Clostridium perfringens via TLR4/TLR15-MyD8 pathway in HD11 avian macrophages

  2020cites this paper
• Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells

  2020cites this paper
• Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade

  2020cites this paper
• Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcus pneumoniae-Specific IgA and Th17 Mediated Protective Immunity

  2020cites this paper
• Hurdles in Cancer Immunotherapy

  2020cites this paper
• T-cell agonists in cancer immunotherapy

  2020cites this paper
• Paracoccidioides brasiliensis infection increases regulatory T cell counts in female C57BL/6 mice infected via two distinct routes.

  2020cites this paper
• OMIP‐067: 28‐Color Flow Cytometry Panel to Evaluate Human T‐Cell Phenotype and Function

  2020cites this paper
• Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft Survival

  2020cites this paper
• CD40 Accelerates the Antigen-Specific Stem-Like Memory CD8+ T Cells Formation and Human Papilloma Virus (HPV)-Positive Tumor Eradication

  2020cites this paper
• Ad-CD40L mobilizes CD4 T cells for the treatment of brainstem tumors

  2020cites this paper
• Insights into the role of C3d dimers in B cell activation and Staphylococcal immune evasion

  2020cites this paper
• Rationale for CD40 pathway blockade in autoimmune rheumatic disorders.

  2020cites this paper